Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Analysis of Circulating Tumor DNA Dynamics to Predict and Monitor Response to Tyrosine Kinase Inhibitors in Patients With Advanced Non-small Cell Lung Cancer

NCT06167460 is registered in ClinicalTrials.gov with Gene Solutions as lead sponsor.

NCT NCT06167460
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06167460 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Analysis of Circulating Tumor DNA Dynamics to Predict and Monitor Response to Tyrosine Kinase Inhibitors in Patients With Advanced Non-small Cell Lung Cancer
Lead sponsor
Gene Solutions
Phase
Observational
Overall status
Recruiting
Start date
December 4, 2023
Completion date
December 1, 2025
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non small cell lung cancer, stage iiib non-small cell lung cancer, stage iiic non-small cell lung cancer, stage iv non-small cell lung cancer, tyrosine kinase inhibitors